// App-Quantinova.ai

e16157 : Unresectable hepatocellular carcinoma treated with lenvatinib or sorafenib: A disease modeling study.

Researchers

Presenter

  • Gabriel Tremblay

Principal Investigators

  • Ronda Copher

  • Shan Ashton Garib

  • Janice Pan

Medical Centers

  • Purple Squirrel Economics, LLC, New York, NY

  • Eisai Inc, Woodcliff Lake, NJ

  • Eisai Inc, Woodcliff Lake, NJ

Locations

  • United States

Companies

  • Purple Squirrel Econ

  • Eisai Inc.

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Alpha-fetoprotein

Drug/Treatment

  • Alfa-fetoprotein

  • Lenvatinib

  • Sorafenib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved